Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 10, 2013, Pages 1708-1714

  Esse, Ruben ^a,b   Florindo, Cristina ^b   Imbard, Apolline ^a,c   Rocha, Mónica S ^a,b   De Vriese, An S ^d   Smulders, Yvo M ^a,e   Teerlink, Tom ^a,e   Tavares de Almeida, Isabel ^b   Castro, Rita ^b   Blom, Henk J ^a,e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LISBON   (Portugal)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d Renal Unit   (Belgium)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

B vitamins deficiency; H3R8 methylation; Homocysteine; Protein methylation; S adenosylhomocysteine

Indexed keywords

ARGININE; DIMETHYLARGININE; GLOBAL PROTEIN; HISTONE; HOMOCYSTEINE; METHIONINE; MONOMETHYLARGININE; PROTEIN; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; ELECTROSPRAY MASS SPECTROMETRY; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERHOMOCYSTEINEMIA; LIVER; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ARGININE METHYLATION; PROTEIN HYDROLYSIS; PROTEIN METHYLATION; RAT; TANDEM MASS SPECTROMETRY; VITAMIN DEFICIENCY;

B VITAMINS DEFICIENCY; H3R8 METHYLATION; HOMOCYSTEINE; PROTEIN METHYLATION; S-ADENOSYLHOMOCYSTEINE;

ANIMALS; ARGININE; DIET; DISEASE MODELS, ANIMAL; FEMALE; HISTONES; HYPERHOMOCYSTEINEMIA; METHYLATION; PROTEINS; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84879581743     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.05.013     Document Type: Article

References (30)

1. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011, 34:75-81.
2. Chen N.C., Yang F., Capecci L.M., Gu Z., Schafer A.I., Durante W., et al. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J. 2010, 24:2804-2817.
3. Finkelstein J.D. Methionine metabolism in mammals. J. Nutr. Biochem. 1990, 1:228-237.
4. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002, 132:2361S-2366S.
5. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003, 49:1292-1296.
6. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 2000, 275:29318-29323.
7. Chen Z., Karaplis A.C., Ackerman S.L., Pogribny I.P., Melnyk S., Lussier-Cacan S., et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10:433-443.
8. Choumenkovitch S.F., Selhub J., Bagley P.J., Maeda N., Nadeau M.R., Smith D.E., et al. In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. J. Nutr. 2002, 132:2157-2160.
9. Pahlich S., Zakaryan R.P., Gehring H. Protein arginine methylation: cellular functions and methods of analysis. Biochim. Biophys. Acta 2006, 1764:1890-1903.
10. Di Lorenzo A., Bedford M.T. Histone arginine methylation. FEBS Lett. 2011, 585:2024-2031.
11. Esse R., Rocha M.S., Barroso M., Florindo C., Teerlink T., Kok R.M., et al. Protein arginine methylation is more prone to inhibition by S-adenosylhomocysteine than DNA methylation in vascular endothelial cells. PLoS One 2013, 8:e55483.
12. Struys E.A., Jansen E.E., de Meer K., Jakobs C. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry. Clin. Chem. 2000, 46:1650-1656.
13. te Poele-Pothoff M.T., van den Berg M., Franken D.G., Boers G.H., Jakobs C., de Kroon I.F., et al. Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 1995, 32(Pt 2):218-220.
14. de Jong S., Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal. Biochem. 2006, 353:287-289.
15. Teerlink T. HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2007, 851:21-29.
16. Boger R.H., Bode-Boger S.M., Sydow K., Heistad D.D., Lentz S.R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1557-1564.
17. Boger R.H., Lentz S.R., Bode-Boger S.M., Knapp H.R., Haynes W.G. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Clin. Sci. (Lond.) 2001, 100:161-167.
18. Selley M.L. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol. Aging 2003, 24:903-907.
19. Stuhlinger M.C., Oka R.K., Graf E.E., Schmolzer I., Upson B.M., Kapoor O., et al. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation 2003, 108:933-938.
20. Yoo J.H., Lee S.C. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 2001, 158:425-430.
21. Dayal S., Lentz S.R. ADMA and hyperhomocysteinemia. Vasc. Med. 2005, 10(Suppl. 1):S27-S33.
22. Paroni R., Fermo I., Fiorina P., Cighetti G. Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects. Amino Acids 2005, 28:389-394.
23. Rocha M.S., Teerlink T., Janssen M.C., Kluijtmans L.A., Smulders Y., Jakobs C., et al. Asymmetric dimethylarginine in adults with cystathionine beta-synthase deficiency. Atherosclerosis 2012, 222:509-511.
24. Wilcken D.E., Wang J., Sim A.S., Green K., Wilcken B. Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function. J. Inherit. Metab. Dis. 2006, 29:30-37.
25. Stead L.M., Brosnan J.T., Brosnan M.E., Vance D.E., Jacobs R.L. Is it time to reevaluate methyl balance in humans?. Am. J. Clin. Nutr. 2006, 83:5-10.
26. Kharbanda K.K. Role of transmethylation reactions in alcoholic liver disease. World J. Gastroenterol. 2007, 13:4947-4954.
27. Verhoeven N.M., Roos B., Struys E.A., Salomons G.S., van der Knaap M.S., Jakobs C. Enzyme assay for diagnosis of guanidinoacetate methyltransferase deficiency. Clin. Chem. 2004, 50:441-443.
28. DiBello P.M., Dayal S., Kaveti S., Zhang D., Kinter M., Lentz S.R., et al. The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia. Mol. Cell. Proteomics 2010, 9:471-485.
29. Reytor E., Perez-Miguelsanz J., Alvarez L., Perez-Sala D., Pajares M.A. Conformational signals in the C-terminal domain of methionine adenosyltransferase I/III determine its nucleocytoplasmic distribution. FASEB J. 2009, 23:3347-3360.
30. Blythe S.A., Cha S.W., Tadjuidje E., Heasman J., Klein P.S. Beta-Catenin primes organizer gene expression by recruiting a histone H3 arginine 8 methyltransferase, Prmt2. Dev. Cell 2010, 19:220-231.